ModivCare — Q2 2023 Earnings Presentation
36 slides from ModivCare's earnings presentation, August 2023
Slide 1: Investor Presentation
Investor Presentation August 2023 © 2023 Modivcare® Inc.
Slide 2: Forward Looking Statements
Forward Looking Statements Certain statements contained in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,”
Slide 3: National Tech-Enabled Platform with Market-Leading Solutions
National Tech-Enabled Platform with Market-Leading Solutions Supportive Integrated Supportive Care Revenue Adj. EBITDA Care Addressing the Social Determinants of Health (SDoH) $2.7B (1) $214M (1) Remote Transportation Personal Care Monitoring ▪ Largest provider of ▪ Leading provider of in- ▪ Leading
Slide 4: Strategy Aligned with CMS' Agenda
Strategy Aligned with CMS’ Agenda CMS STRATEGIC PILLARS ADVANCE EXPAND ENGAGE DRIVE PROTECT FOSTER EQUITY ACCESS PARTNERS INNOVATION PROGRAMS EXCELLENCE Strategic Alignment © 2023 Modivcare® Inc. 4
Slide 5: Solutions Address Key Market Trends
Solutions Address Key Market Trends Combining supportive care alongside clinical care improves access, reduce costs, and improves outcomes Solutions Addressing SDoH Reduce Cost to Healthcare Ecosystem SDoH providers that connect patients to services that meet their needs outside traditional settings
Slide 6: Enhancing Member Experience Through Operational Excellence
Enhancing Member Experience Through Operational Excellence NEMT PCS RPM On-Time Performance Caregiver Retention Member Engagement 92% 67% 66% 80% 59% 60% 2Q22 2Q23 2Q22 2Q23 2Q22 2Q23 © 2023 Modivcare® Inc. 6
Slide 7: Investment Highlights
Investment Highlights Solutions Address Needs of a Large, Growing Complex & Chronic Population Leading Market Positions with Differentiated Value Proposition in Attractive End-Markets Significant Opportunity to Pursue Profitable Growth with $150B Market Whitespace Leveraging Technology to Realize Ef
Slide 8: Business Segments
Business Segments | | [| modivcare
Slide 9: Non-Emergency Medical Transportation (NEMT)
Non-Emergency Medical Transportation (NEMT)
Slide 10: Non-Emergency Medical Transportation (NEMT)
Non-Emergency Medical Transportation (NEMT) Core Services NEMT Differentiators Multi-modal levels of service providing access to clinical care Size and Scale – Largest provider in the U.S. v Traditional Providers v Wheelchair Accessible Deepest Transportation Network – Strong relationships with thir
Slide 11: NEMT | Business Model & LTM Results
NEMT | Business Model & LTM Results Metric Driver Notes LTM 2Q23 Monthly Members $1,885M Revenue x PMPM driven by pricing/mix changes 34.7M Members and ~65% flow-through of % change $4.53 PMPM Revenue Per Member Per Month in Transportation Costs per member Trips (Utilization x Members) Transportatio
Slide 12: NEMT | Growth and Margin Outlook
NEMT | Growth and Margin Outlook Membership Growth Outlook Adj. EBITDA Margin Outlook 4% - 5% 3% - 4% ~10% 8% 2 4 2 3 3 (1%) - (2%) 3% - 4% 3% - 4% (0%) – (1%) 1 (4%) – (5%) 1 Existing Client Expected Medicaid & Redetermination Annual Membership Adj. EBITDA Net Wins & Utilization Cost Initiatives Ad
Slide 13: NEMT | Initiatives to Optimize Cost Structure
NEMT | Initiatives to Optimize Cost Structure Description Next 12-18 Months Savings Annualized Savings ▪ Automated, omni-channel communications, leading to reduction in: ✓ ~75% Ride Assist Calls Eliminated $25 - $35 million $40 - $60 million Contact Center Optimization ✓ ~50% Intake & Reservations C
Slide 14: NEMT | Expense Trends
NEMT | Expense Trends Cost saving initiatives expected to offset higher Transportation Costs 1 Historical Trends Transportation in Transportation Cost Per Paid Trip Cost Per Member 2 Transportation Cost Inflation $43 ~$43 3% - 5% $36 $33 $32 $31 0% - 1% Base Annual Base Public Transit Mileage Reduce
Slide 15: NEMT | Medicaid Redetermination Update
NEMT | Medicaid Redetermination Update Modivcare is closely tracking redetermination, with initial national and state-level disenrollment progress in-line with expectations ▪ Medicaid’s continuous enrollment provision, which had halted Redetermination Projections disenrollments since March 2020, end
Slide 16: Personal Care Services (PCS)
Personal Care Services (PCS)
Slide 17: Personal Care Services (PCS)
Personal Care Services (PCS) Core Services PCS Differentiators Non-medical personal care services improving activities of daily living Scale and Density – Leading provider in the Northeast v Meal Preparation v Mobility Assistance Recruitment and Retention – Industry leading retention v Personal Hygi
Slide 18: PCS | Business Model & LTM Results
PCS | Business Model & LTM Results Metric Driver Notes LTM 2Q23 Hours driven by new patient referrals and Hours recruitment of caregivers $700M Revenue x Rates established by States and Payors 27.4M Hours Reimbursement Per Hour subject to legislative, budgetary and other ~$25.51 Revenue/Hour risks H
Slide 19: Remote Patient Monitoring (RPM)
Remote Patient Monitoring (RPM)
Slide 20: Remote Patient Monitoring (RPM)
Remote Patient Monitoring (RPM) Core Services RPM Differentiators Scale and Density – 45 states with a diverse payor customer base v Personal Emergency Response Systems v Vitals / Chronic Condition Monitoring Device Agnostic – Integrated with emerging / future technologies v Medication Management In
Slide 21: RPM | Business Model & LTM Results
RPM | Business Model & LTM Results Metric Driver Notes LTM 2Q23 Clients driven by existing market growth, Clients new contracts, and cross-selling initiatives, partly offset by normal churn $76M Revenue x \ Contracted rates established by States and ~235K Avg. Clients Contracted Rate Payors ~$26.78
Slide 22: Financial Summary
Financial Summary | | [| modivcare
Slide 23: Financial Overview
Financial Overview Business Mix Historical Performance ($ in millions) Remote NEMT Personal Care RPM Monitoring $2,663 $2,504 Personal 3% Care Revenue 26% $1,997 Mix (1) $1,369 71% NEMT 2020 2021 2022 LTM 6/30/23 Remote Monitoring 11% $222 $214 $205 Personal Adj. EBITDA Care $169 Mix (1) 30% 59% NEM
Slide 24: Attractive Asset-Light & Profitable Growth Financial Profile
Attractive Asset-Light & Profitable Growth Financial Profile ▪ Modivcare has generated consistent operating growth on Recent Financial Performance ($ in millions) a quarterly basis Revenue Adj. EBITDA $699 $628 $648 $654 $662 $575 ▪ Stable revenue base characterized by strong client $60 $60 retentio
Slide 25: 2023 Revised Guidance
2023 Revised Guidance ($ in millions) Consolidated Metrics 2023 Revised Guidance Revenue $2,750 – $2,800 Adjusted EBITDA $200 – $210 % Adj. EBITDA Margin 7.1% – 7.6% Note: 2023 outlook excludes impact of M&A © 2023 Modivcare® Inc. 25
Slide 26: Capitalization
Capitalization Capital Allocation Priorities Balance Sheet ($ in millions) 6/30/2023 Leverage Metrics (1) ▪ Debt Repayment High priority in order to enable higher return options Cash & Cash Equivalents $7 Revolving Credit Facility due 2027 ($325) 127 ▪ Organic Growth Funded with internal cash flow 5
Slide 27: Appendix
Appendix | | [| modivcare
Slide 28: Medicaid and Medicare Outlook
Medicaid and Medicare Outlook Medicaid (incl. CHIP) Enrollment Projections (1) Medicare Enrollment Projections (2) On average, over 2022-2031, Medicaid expenditures are projected to grow by 5.0%. With the end of the continuous enrollment condition in 2023, Medicaid enrollment is projected to decline
Slide 29: Modivcare Membership Detail
Modivcare Membership Detail Membership growth has outpaced the market, increasing penetration in Medicaid & MA plans nationally 34.2 (in millions) 29.7 27.0 6.6 4.4 3.3 MODV Medicaid Membership MODV Medicare Membership 27.6 23.7 25.3 2020 2021 2022 Medicaid 6.7% 9.3% MODV % Growth Medicare Advantage
Slide 30: NEMT | Illustrative Unit Economics – Shared-Risk Contracts
NEMT | Illustrative Unit Economics – Shared-Risk Contracts Income Statement Normal Utilization Low Utilization High Utilization Key Components 1 Revenue per Member per Year $100.00 $100.00 $100.00 1 Revenue per year remains constant during 2 periods of normal, low, and high utilization (Plus) Increm
Slide 31: Non-GAAP Reconciliation
Non-GAAP Reconciliation Reconciliation of Adjusted EBITDA of Modivcare (dollars in thousands) FY 2019 FY 2020 1Q21 2Q21 3Q21 4Q21 FY 2021 1Q22 2Q22 3Q22 4Q22 FY2022 1Q23 2Q23 LTM 2Q23 Net income (loss) ($4,953) $89,614 $18,840 $13,672 ($7,572) ($31,525) ($6,585) $318 $3,328 ($28,505) ($6,947) ($31,8
Slide 32: Non-GAAP Reconciliation | FY2022
Non-GAAP Reconciliation | FY2022 Notes to Reconciliation of Adjusted EBITDA 1. Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees. 2. Transaction and integration costs consist of fees incurred
Slide 33: Non-GAAP Reconciliation | FY2021
Non-GAAP Reconciliation | FY2021 Notes to Reconciliation of Adjusted EBITDA 1. Restructuring and related costs include professional fees for strategic initiatives and severance and office closure costs. 2. Transaction and integration costs consist of fees incurred in the acquisitions of Care Finders
Slide 34: Non-GAAP Reconciliation – NEMT
Non-GAAP Reconciliation – NEMT NEMT Segment Reconciliation of Non-GAAP Financial Measures Twelve Months Ended Jun 30 (dollars in thousands) 2023 Net income $72,798 Provision (benefit) for income taxes 16,254 Interest expense, net - Depreciation and amortization 27,717 NEMT Reported EBITDA $116,769 R
Slide 35: Non-GAAP Reconciliation – PCS
Non-GAAP Reconciliation – PCS PCS Segment Reconciliation of Non-GAAP Financial Measures Twelve Months Ended Jun 30 (dollars in thousands) 2023 Net income ($121,417) Provision (benefit) for income taxes 3,664 Interest expense, net - Depreciation and amortization 51,708 PCS Reported EBITDA ($66,045) R
Slide 36: Non-GAAP Reconciliation – RPM
Non-GAAP Reconciliation – RPM RPM Segment Reconciliation of Non-GAAP Financial Measures Twelve Months Ended Jun 30 (dollars in thousands) 2023 Net income ($43,232) Provision (benefit) for income taxes 771 Interest expense, net - Depreciation and amortization 23,033 RPM Reported EBITDA ($19,428) Rest